About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting

Welcomes Recent Announcement by Novavax of Licensing Agreement with Sanofi

Stresses Significant Value Still Remains to Be Unlocked at Novavax

Still Believes Novavax Would Benefit from Stockholder Representative on Board

RALEIGH, N.C., May 20, 2024 (GLOBE NEWSWIRE) -- Shah Capital Management, Inc. (together with its affiliates, “Shah Capital,” “we” or “our”) collectively beneficially owns ~7.9% of the outstanding common stock of Novavax, Inc. (NASDAQ: NVAX) (“Novavax” or the “Company”), making it a top three and largest non-index stockholder, today issued the below statement to stockholders regarding its intended efforts at the 2024 Annual Meeting of Stockholders scheduled for Thursday, June 13, 2024, 8:30 a.m. Eastern Time (the “2024 Annual Meeting”):

***

Fellow Novavax Stockholders:

As a long-term strategic investor, we have been engaging with the board of directors of Novavax (the “Board”) for over a year in an attempt to unlock value on behalf of all of its shareholders, so it is heartening that our campaign has begun to deliver positive results. We long advocated for Novavax to explore potential strategic partnership opportunities and believe that the Company’s recent announcement of its entry into a co-exclusive licensing agreement with Sanofi is a long-awaited step in the right direction.

It is unfortunate, however, that it took our campaign to galvanize the Board into action. In our view, the Board presided over numerous enormous strategic errors, including colossal marketing failures in 2023-2024 season, no clear understanding of AI technology to effectively improve vaccine research efforts both on time and money, questionable regulatory management, and ongoing operating losses plus the massive dilutive share issuance at low price in 2023. It is also regrettable that the Board took so long to execute 50%+ cost cutting in light of massive prior losses that we asked for back in March 2023, taking them a year to follow through on the cuts.

However, we do accept that decent progress has now at last been made and that is why we have determined to withdraw our proxy campaign against the re-election of directors at Novavax’s 2024 Annual Meeting. But that does not mean that our engagement is at an end. We will continue to closely monitor the Company, including its operations, especially marketing, as we believe significant additional value remains to be unlocked at Novavax.

We also continue to believe that Novavax would benefit from the addition of a stockholder representative in the boardroom, one of the main reasons why we believe the Company ended up in such poor shape, and it is important that this be addressed.

We also reiterate our position that Novavax must adopt an aggressive and patient-driven sales and marketing strategy capitalizing on numerous peer-reviewed scientific papers showing lower efficacy and safety profile of competing vaccines.

At the heart of our campaign was our desire that Novavax’s scientifically proven protein-based vaccine franchise play a major role globally resulting in sustained profitable growth and we will be watchful of their progress. We thank thousands of fellow shareholders who supported Shah Capital in our campaign and who shared our concerns about the direction of the Company. Together, we have helped to deliver real change at Novavax.

Sincerely,

Shah Capital Management, Inc.

***

About Shah Capital:

Shah Capital is a global investment firm employing a focused investment philosophy with an emphasis on turnarounds and special situations.

Media Contacts:

Citigate Dewe Rogerson
Shah Capital team

shahcapital@citigatedewerogerson.com

Primary Logo

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.